Literature DB >> 17875636

Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.

Martin Rottman1, Emilie Catherinot, Patrick Hochedez, Jean-François Emile, Jean-Laurent Casanova, Jean-Louis Gaillard, Claire Soudais.   

Abstract

Mycobacterium abscessus is an emerging rapidly growing mycobacterium that causes tuberculous-like lesions in humans. We studied the immune control of this organism in C57BL/6 mice challenged intravenously with 10(7) CFU. Bacteria were eliminated from both the spleen and the liver within 90 days, and liver histology showed organized granulomatous lesions. A T- and B-cell requirement was investigated by challenging Rag2-/-, Cd3epsilon-/-, and muMT-/- mice. Rag2-/- and Cd3epsilon-/- mice were significantly impaired in the ability to clear M. abscessus from the liver and spleen, and muMT-/- mice were significantly impaired in the ability to clear M. abscessus from the liver, suggesting that infection control was primarily T cell dependent in the spleen and both T and B cell dependent in the liver. The liver granulomatous response was similar to that of wild-type controls in muMT-/- mice but completely absent in Cd3epsilon-/- and Rag2-/- mice. We studied the involvement of gamma interferon (IFN-gamma) and tumor necrosis factor (TNF) by challenging C57BL/6 mice deficient in the IFN-gamma receptor (Ifngr1-/-) and in TNF (Tnf-/-). Ifngr1-/- mice were significantly impaired in M. abscessus control both in the spleen and in the liver, and granulomas were profoundly altered. The effect was even more substantial in Tnf-/- mice; they failed to control M. abscessus infection in the liver and died within 20 to 25 days after infection with many hepatic inflammatory foci and major lesions of ischemic necrosis in the liver and kidney. These features were not observed with the closely related species M. chelonae. T-cell immunity, IFN-gamma, and TNF are central factors for the control of M. abscessus in C57BL/6 mice, as they are for the control of pathogenic slowly growing mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875636      PMCID: PMC2168332          DOI: 10.1128/IAI.00014-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab.

Authors:  I Marie; P Heliot; F Roussel; F Hervé; J F Muir; H Levesque
Journal:  Rheumatology (Oxford)       Date:  2005-06-07       Impact factor: 7.580

3.  Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection.

Authors:  T F Byrd; C R Lyons
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction.

Authors:  A Villanueva; R V Calderon; B A Vargas; F Ruiz; S Aguero; Y Zhang; B A Brown; R J Wallace
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.

Authors:  Shabaana A Khader; John E Pearl; Kaori Sakamoto; Leigh Gilmartin; Guy K Bell; Dawn M Jelley-Gibbs; Nico Ghilardi; Fred deSauvage; Andrea M Cooper
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

6.  Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Authors:  Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

7.  Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.

Authors:  T M Doherty; A Sher
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

8.  Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.

Authors:  Susan E Dorman; Capucine Picard; David Lammas; Klaus Heyne; Jaap T van Dissel; Richard Baretto; Sergio D Rosenzweig; Melanie Newport; Michael Levin; Joachim Roesler; Dinakantha Kumararatne; Jean-Laurent Casanova; Steven M Holland
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

9.  Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium.

Authors:  S Ehlers; J Benini; S Kutsch; R Endres; E T Rietschel; K Pfeffer
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

10.  hsp65 sequencing for identification of rapidly growing mycobacteria.

Authors:  H Ringuet; C Akoua-Koffi; S Honore; A Varnerot; V Vincent; P Berche; J L Gaillard; C Pierre-Audigier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more
  50 in total

1.  Acute respiratory failure involving an R variant of Mycobacterium abscessus.

Authors:  Emilie Catherinot; Anne-Laure Roux; Edouard Macheras; Dominique Hubert; Moussa Matmar; Luc Dannhoffer; Thierry Chinet; Philippe Morand; Claire Poyart; Beate Heym; Martin Rottman; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

2.  Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus.

Authors:  Jong-Seok Kim; Min-Jung Kang; Woo Sik Kim; Seung Jung Han; Hong Min Kim; Ho Won Kim; Kee Woong Kwon; So Jeong Kim; Seung Bin Cha; Seok-Yong Eum; Won-Jung Koh; Sang-Nae Cho; Jong-Hwan Park; Sung Jae Shin
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

3.  Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

4.  Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy.

Authors:  Kerstin Pohl; Xue A Grimm; Silvia M Caceres; Katie R Poch; Noel Rysavy; Milene Saavedra; Jerry A Nick; Kenneth C Malcolm
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

5.  MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection.

Authors:  Vincent Le Moigne; Claudine Belon; Céline Goulard; Geoffrey Accard; Audrey Bernut; Bruno Pitard; Jean-Louis Gaillard; Laurent Kremer; Jean-Louis Herrmann; Anne-Béatrice Blanc-Potard
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

6.  Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.

Authors:  Michal Meir; Tatyana Grosfeld; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice.

Authors:  Jean Claude Bakala N'Goma; Vincent Le Moigne; Nathalie Soismier; Laura Laencina; Fabien Le Chevalier; Anne-Laure Roux; Isabelle Poncin; Carole Serveau-Avesque; Martin Rottman; Jean-Louis Gaillard; Gilles Etienne; Roland Brosch; Jean-Louis Herrmann; Stéphane Canaan; Fabienne Girard-Misguich
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

8.  MyD88 signaling in CD4 T cells promotes IFN-γ production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection.

Authors:  Yubin Zhang; Maura Jones; Amanda McCabe; Gary M Winslow; Dorina Avram; Katherine C MacNamara
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

9.  The antioxidant mimetic, MnTE-2-PyP, reduces intracellular growth of Mycobacterium abscessus.

Authors:  Rebecca E Oberley-Deegan; Young Min Lee; G Eli Morey; Danielle M Cook; Edward D Chan; James D Crapo
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

10.  Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus.

Authors:  Fabienne Ripoll; Sophie Pasek; Chantal Schenowitz; Carole Dossat; Valérie Barbe; Martin Rottman; Edouard Macheras; Beate Heym; Jean-Louis Herrmann; Mamadou Daffé; Roland Brosch; Jean-Loup Risler; Jean-Louis Gaillard
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.